Target Advancement Program MJFF - Fall 2015
Event details
| Date | 27.05.2015 |
| Speaker | Michael J. Fox Foundation |
| Category | Call for proposal |
The Michael J. Fox Foundation believes that a major hurdle in the development of promising treatments for Parkinson's disease is the lack of well-validated targets linked to the disease process. By promoting critical target validation studies within academic and industry laboratories, MJFF investments can de-risk subsequent drug development and ultimately accelerate the creation of innovative therapies for Parkinson's patients. Part of our Edmond J. Safra Core Programs for PD Research, the Target Advancement program seeks to build robust evidence to rationalize biological pathways and targets for further translation into new Parkinson's treatments.
Source
Source
Links
Practical information
- General public
- Free
Organizer
- Research Office